Form EFFECT Nautilus Biotechnology,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 18, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Carl's Jr.® Is Coming for the King's Crown and Inviting Fans to Trade It for a Better Burger
- Recommendable Launches AI Visibility Service Helping UK Businesses Get Recommended by ChatGPT, Gemini and Google AI Overviews
- Lion Group Holding Ltd. Reaffirms Long-Term Commitment to Hyperliquid (HYPE) Holdings
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share